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Purpose Hypospadias is a common congenital malformation of the male external genitalia. 
Association studies for single nucleotide polymorphisms (SNPs) in genes encoding steroid-5-alpha-
reductase (SRD5A2), estrogen receptors 1 (ESR1) and 2 (ESR2), and activating transcription factor 3 
(ATF3) have been equivocal. The aim of this study was to examine whether non-replication of 
findings for four SNPs in these genes could be due to interaction with environmental exposures.  
Materials and Methods We genotyped 712 Dutch hypospadias case-parent triads for the four SNPs, 
used questionnaire information to determine exposures, and performed association tests using the log-
linear approach. We studied gene-environment interactions for the four SNPs with exposure to 
estrogens, cytokines or cigarette smoke, multiple pregnancy, being born small for gestational age, and 
maternal hypertension or preeclampsia, high BMI, or primiparity. In addition, the presence of maternal 
genetic and parent-of-origin effects was tested. 
Results Gene-environment interactions were identified for rs523349 in SRD5A2 with estrogen 
exposure and maternal hypertension or preeclampsia, as well as for rs11119982 in ATF3 with 
exposure to cytokines. Both SNPs only seemed to influence hypospadias risk in exposed cases. For 
rs6932902 in ESR1, only maternally derived alleles appeared to increase hypospadias risk in offspring.  
Conclusions This study shows that interactions between genetic and environmental factors may help 
to explain non-replication in genetic studies of hypospadias.  
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Hypospadias is a congenital hypoplasia of the penis, resulting from developmental arrest of urethral 
fusion. This leads to displacement of the urethral opening along the ventral side of the penis. 
Hypospadias is one of the most common birth defects among boys, affecting 0.3-0.7% of newborn 
boys in Europe1. It shows familial clustering and segregation analyses suggest that the majority of 
cases have a multifactorial etiology2, involving both genes and environmental factors.  
Some environmental factors have consistently been associated with hypospadias. Hypospadias 
occurs more often in children born small for gestational age (SGA), and in first, intracytoplasmic 
sperm injection (ICSI)-induced, or multiple pregnancies. In addition, maternal hypertension, 
preeclampsia, high body mass index (BMI), pre-existing diabetes, and use of anti-epileptic drugs 
increase hypospadias risk, as does maternal intra-uterine exposure to diethylstilbestrol (DES)1.  
Genetic associations with hypospadias have also been reported, mainly for single nucleotide 
polymorphisms (SNPs) in endocrine-related genes, such as those encoding estrogen receptors 1 
(ESR1)3 and 2 (ESR2)4, activating transcription factor 3 (ATF3)5, and steroid-5-alpha-reductase 
(SRD5A2)6.7. ATF3 is an estrogen-responsive gene showing upregulation in hypospadias8, while 
SRD5A2 encodes an enzyme that converts circulating testosterone in the genital tubercle to the more 
potent androgen dihydrotestosterone.  
The numbers of samples analyzed in these genetic studies were relatively small, and most 
associations could not be replicated in a much larger study by our group9.  
This lack of consistency might reflect differences in environmental exposures between 
populations9. Several reviews have called for studies simultaneously examining genes and 
environment in relation to hypospadias1,10, but so far, such studies have rarely been performed. 
Therefore, we set out to examine whether the lack of replication could be due to gene-environment 
interactions between the four SNPs described above and risk factors for hypospadias.  
In addition to gene-environment interactions, other (epi)genetic mechanisms may be involved 
in the etiology of hypospadias. Maternal genotype may affect the intra-uterine environment, thus 
modulating hypospadias risk, and gene imprinting may cause the copy derived from one parent to be 
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more fully expressed than the copy derived from the other parent11. Therefore, we also examined the 
maternal genotype and imprinting effects.  
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Cases and parents 
AGORA (Aetiologic research into Genetic and Occupational/environmental Risk factors for 
Anomalies in children) is a large data- and biobank at the Radboud University Nijmegen Medical 
Centre in the Netherlands, in which questionnaire data and DNA samples are collected from patients 
with congenital malformations or childhood cancer and their parents. For the current study, DNA was 
available from 796 hypospadias cases born between 1980 and 2008 and 1,422 parents. Medical 
records of all cases were reviewed to identify syndromic hypospadias cases, collect clinical 
characteristics, and obtain information about anatomical location of the urethral opening. The regional 
Committee on Research Involving Human Subjects approved the study protocol and all parents and 
children over 11 years of age gave written informed consent.  
 
Environmental risk factor data 
Questionnaires were sent to the parents of all patients, containing a variety of questions on health and 
lifestyle just before and during pregnancy, which were used to define environmental risk factors. 
Although exogenous exposure to estrogens is not a known risk factor for hypospadias1, we included it 
in the gene-environment interaction analyses, because SRD5A2, ESR1, and ESR2 are involved in 
endocrine processes and ATF3 is an estrogen-responsive gene. Exogenous exposure to estrogens was 
defined as continued use of oral contraceptives during early pregnancy or consumption of soy or 
linseed products, which contain high amounts of phytoestrogens12, at least once a week in the first 14 
weeks after conception. Women with a hormonal coil implanted who became pregnant were excluded 
because of weak estrogen exposure. Women exposed to pesticides at work were also excluded because 
pesticides can have either estrogenic or anti-estrogenic effects.  
In addition, we studied interactions with factors associated with hypospadias occurrence: SGA 
(defined as birth weight<10th percentile for that gestational age, using Dutch reference curves13), 
mothers with hypertension or preeclampsia, high BMI (defined as BMI>25 kg/m2), primiparity, and 
multiple pregnancy.  
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In most tissues, ATF3 mRNA can be induced by various stress signals, such as cytokines and 
chemicals from cigarette smoke14,15. Therefore, we also included these exposures in the gene-
environment interaction analyses for ATF3. Because the placental barrier may be permeable to 
cytokines16,17 and chemicals from cigarette smoke18, we categorized cases whose mothers smoked at 
least one cigarette per day during some time in the first 14 weeks after conception as exposed to 
cigarette smoke, and cases whose mothers reported the presence of an infection and/or inflammation in 
this period as exposed to cytokines.  
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Genotyping 
Blood was collected in EDTA containing tubes (n=1,405) or saliva using Oragene containers (n=687; 
DNA Genotek Inc., Ottawa, Canada). DNA extraction and genotyping was performed as described 
previously9.  
 
Statistical analyses 
We used the case-parent triad design. The most frequent homozygous genotypes in parents served as 
reference genotypes in the log-linear approach19 that was applied to assess genetic associations. Log-
linear models were fitted without assumption of Hardy-Weinberg equilibrium (HWE). Information on 
families with one missing parental genotype was included in the analyses using the expectation-
maximization algorithm20. Likelihood ratio tests (LRT), comparing full models including both mater-
nal and offspring genotypes to reduced models including either maternal or offspring genotype only, 
were computed to determine the relevance of maternal and offspring genotypes for hypospadias risk. 
We also conducted these analyses separately for the groups of anterior, middle, and posterior 
hypospadias cases, because different risk factors may be responsible for the different phenotypes21,22. 
Although the case-parent triad design is robust to population-stratification when testing genetic 
effects, effects of environmental exposures cannot be estimated. 
Parent-of-origin analyses were conducted in two steps. As an initial screening, we used the 
transmission asymmetry test (TAT)19. This approach provides insights into the data, but is invalid 
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when maternal effects exist. Therefore, the parent-of-origin LRT (PO-LRT), was used to confirm the 
results23.  
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 Interactions between environmental exposures and offspring genotypes were tested using  log-
linear models with the LRT comparing a full model including gene-environment interactions to a 
reduced model including only the offspring genotypic effect24. We used a dominant interaction 
parameter, assuming that the environmental factor affects carriers with one or two copies of the variant 
allele similarly. We did not correct the critical P-value for multiple testing, as we only tested a limited 
number of well-founded  hypotheses. If the LRT indicated the presence of an interaction (PLRT<0.05), 
relative risks (RR) and 95% confidence intervals (95% CI) were calculated separately for the different 
strata of the exposure variable using the variance calculated with the LEM program, which takes into 
account missing genotypes25. All other analyses were performed using the SAS System for Windows, 
release 8.02 (SAS Institute, Cary, North Carolina). 
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Of the 796 available hypospadias cases, 38 patients were excluded due to lack of parental DNA. To 
ensure independence, we excluded the youngest brother from 22 sib-pairs, while from three twin-pairs, 
one brother was excluded at random. We excluded 19 patients because of syndromic hypospadias, 
chromosome abnormalities, or a known cause of hypospadias. Finally, two triads were excluded 
because of Mendelian errors. The final data set consisted of 712 cases. For 668 cases, DNA of both 
parents was available, while for 44 cases, we only had DNA from one parent. Environmental data 
were missing for 70 families. The majority of cases were of European Caucasian descent (91%), and 
the remaining were of non-European (5%) or unknown descent (4%). Almost 60% of cases had an 
anterior hypospadias, while 20% and 13% had middle and posterior urethral openings, respectively. 
Table 1 shows the distribution of the environmental risk factors studied. Exogenous exposure to 
estrogens, multiple pregnancies and fetal exposure to cytokines were relatively rare (<10%), whereas 
the other factors were more common. 
Genotyping of the SNPs was completed with a success rate of more than 98.5%. All genotype 
frequencies in parents were in HWE (P≥0.28). Genetic association results showed that offspring 
genotype of the variant in ESR1 was associated with hypospadias, as reported earlier in a partly 
overlapping sample9, whereas results for the variant in ATF3 were suggestive of an association. 
Maternal genotypes were not associated with hypospadias in offspring (Table 2). Repeating the 
analyses separately for subgroups of anterior, middle, and posterior hypospadias cases showed 
comparable results.  
The results of the gene-environment interaction analyses pointed towards interactions between 
offspring genotype of rs523349 in SRD5A2 and exogenous estrogen exposure and maternal 
hypertension or preeclampsia (Table 3). Offspring carrying the variant allele seemed to be at increased 
risk of hypospadias when estrogen exposure occurred and at decreased risk when the mother had 
hypertension or preeclampsia. Furthermore, an interaction was observed between rs11119982 in ATF3 
and exposure to cytokines, with an increased risk of hypospadias for offspring carrying the variant 
allele only when the mother reported an infection and/or inflammation (Figure 1). Due to small 
numbers of cases with certain exposures, we also considered a reduced model assuming HWE, which 
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handles small sample size situations better. The risk estimates from this model showed the same 
direction of gene by exposure interaction for the SNP in SRD5A2 and exogenous estrogen exposure, 
albeit less strongly (Figure 2). For the other interactions, similar results were obtained as in the full 
model. 
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The results of the parent-of-origin effects analyses are shown in Table 4. For rs6932902 in 
ESR1, the estimated PO-LRT relative risk for an imprinting effect was 1.61 (95% CI=1.02-2.53), 
indicating that a maternally derived copy seemed to be associated with a greater risk of hypospadias 
than a paternally derived copy. The TAT showed that only the maternally derived copy increased the 
risk of hypospadias (RR=1.8, 95% CI=1.3-2.7).   
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This study is a follow-up to our earlier association study of genetic variants in SRD5A2, ESR1, ESR2, 
and ATF3 and hypospadias risk in which 620 cases were included. For the current study, we excluded 
37 cases because DNA of both parents was not available or a brother was present in the dataset, and 
included 129 cases not included in the earlier study because of non-Caucasian or unknown ethnicity or 
because they were collected after 2007. We included gene-environment interactions as well as 
maternal and parent-of-origin effects in an attempt to reconcile our findings with those of others.  
The estimated interaction between offspring genotype of the SNP in SRD5A2 and exogenous 
estrogen exposure during early pregnancy suggests that offspring carrying the variant have a more 
than eight fold increased risk of hypospadias only in case of exogenous estrogen exposure in the full 
log-linear model, and an almost three times increased risk in the reduced model. The interaction 
between this variant in SRD5A2 and exogenous estrogen exposure seems biologically plausible, as it  
causes a valine to leucine substitution (V89L)  resulting in an approximately 30% decrease in enzyme 
activity26 and thus in less dihydrotestosterone. Additional estrogen exposure might cause an androgen-
estrogen imbalance in carriers of this variant, resulting in hypospadias. The gene-environment 
interaction observed could help to explain differences in findings for this SNP between our study and 
studies from Sweden and China6,7,9. The latter two observed associations with the malformation, not 
taking environmental parameters into account, while we did not. However, phytoestrogen exposure is 
known to be higher in Chinese and Swedish populations compared to the Dutch. Chinese people 
consume more soy products, while in Nordic countries more rye bread and berries are consumed. 
These food products contain large amounts of isoflavonoids and lignans, respectively, whereas in a 
typical Western diet, both lignans and isoflavonoids are almost completely lacking27.  
The SNP in SRD5A2 seemed to decrease hypospadias risk in case of maternal hypertension or 
preeclampsia, which may result from placental insufficiency. The latter may also lead to decreased 
provision of human chorionic gonadotropin (hCG) to the foetus. As hCG stimulates foetal testicular 
steroidogenesis before the foetus’s own pituitary-gonadal axis is established, and the SNP in SRD5A2 
may result in even less DHT being formed, we would expect the SNP to increase hypospadias risk in 
case of maternal hypertension or preeclampsia. 
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The SNP in ATF3 seemed to be associated with an increased hypospadias risk only when the 
mother reported an infection and/or inflammation during pregnancy. ATF3 shows strong upregulation 
in hypospadias patients8 and is upregulated in response to cytokines14. While the rs11119982 variant 
has not been functionally characterized, a working hypothesis could be that the variant underlying the 
association with hypospadias causes an increased expression of ATF3 in response to cytokines. 
However, this finding does not reconcile our results with those reported earlier, describing a decreased 
hypospadias risk in the presence of the variant5.  
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The parent-of-origin analyses indicated that only a maternally derived copy of the variant in 
ESR1 seems to be associated with an increased hypospadias risk. This suggests that the maternally 
derived allele of ESR1 is more fully expressed than the paternally derived allele. Although ESR1 is not 
one of the currently known imprinted genes (www.geneimprint.com), the experimental identification 
of imprinted genes is challenging, because monoallelic expression of imprinted genes may occur only 
in particular tissues, at particular stages of development, or in one of the isoforms28. Therefore, it is 
unlikely that all human imprinted genes are already known. However, the observed parent-of-origin 
effect could also have arisen from an effect of maternal-fetal genotype interaction. Unfortunately, we 
do not have enough statistical power to disentangle these two possible effects. 
We have to acknowledge some limitations. For all factors studied, we relied on information 
from questionnaires which may result in misclassification due to recall problems, especially since the 
average time between birth and filling out the questionnaires was 10.2 years, ranging from 0 to 27 
years. However, most factors studied are relatively easy to remember. Also, this misclassification 
probably does not depend on genotype and  would have resulted in attenuation of the results only, 
which may have obscured some effects. Misclassification due to measurement error could also account 
for not finding gene-environment interactions for well-known factors such as SGA or primiparity, 
which may be proxies for underlying causes that are difficult to measure, such as placental 
insufficiency. To our knowledge, we investigated the largest sample of hypospadias cases thus far 
reported in genetic studies, while the power of our study was further increased by including 
information on families with one missing parental genotype using the expectation-maximization 
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algorithm. Nevertheless, numbers of cases having a specific genotype and being exposed to a 
particular environmental risk factor were still small, resulting in large confidence intervals for the 
effect estimates. Our definition of exogenous estrogen exposure, for example, assured a selective 
group of women experiencing high levels of exposure, but resulted in low numbers of exposed 
women. This indicates that very large samples are needed to study gene-estrogen-exposure 
interactions. In addition, the gene-environment interaction test assumes that the SNP under study is a 
disease-causing mutation. If a marker in linkage disequilibrium with the causative mutation is studied 
instead, the test is susceptible to exposure-related population-stratification29. 
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We showed that parent-of-origin effects and gene-environment interactions contribute to the etiology 
of hypospadias, and that environmental factors can explain genetic non-replication between studies. 
Our results warrant further research directed at elucidating combined effects of genetic and 
environmental factors for this frequently occurring urological birth defect. 
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Tables 
 
Table 1.  Distribution of environmental risk factors for hypospadias patients. 
 
Exposure 
 
 
       yes 
    n      (%)  
 
 
       no 
    n      (%)  
 
 
   unknowna 
    n      (%) 
 
Exogenous exposure to estrogens    29     (4%) 
 
580   (81%) 
 
103   (14%) 
 
 Use of oral contraceptives during pregnancy       8      (1%)  626    (88%) 
  
   78    (11%) 
 
 Consumption of soy products during pregnancy    16      (2%)   620    (87%) 
  
   76    (11%) 
 
 Consumption of linseed products during pregnancy      7      (1%)  626    (88%) 
 
   79    (11%) 
 
Known hypospadias risk factors   
 
 
 Small for gestational age 125   (18%) 505   (71%)   82   (12%) 
 
 Hypertension or preeclampsia 107   (15%) 533   (75%)   72   (10%) 
 
 BMI > 25 kg/m2 140   (20%) 468   (66%) 104   (15%) 
 
 First pregnancy 361   (51%) 277   (39%)   74   (10%) 
 
 Multiple pregnancy   49     (7%) 590   (83%)   73   (10%) 
 
Fetal exposure to cytokines   67     (9%) 499   (70%) 146   (21%) 
 
 From a severe cold    15       (2%)  574    (81%)  123    (17%) 
 
 From other viral, bacterial or fungal infections    28       (4%)  563    (79%)  121    (17%) 
 
 From chronic inflammatory diseases    29       (4%)  605    (85%)    78    (11%) 
 
Fetal exposure to cigarette smoke 117   (16%) 505   (71%)   90   (13%) 
 
Percentages do not add up to 100% due to rounding and overlapping categories; n, number; afor 70 
patients, environmental data were completely missing because parents did not fill out the 
questionnaires. 
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Table 2.  Genetic association results for offspring and maternal genotypes of single nucleotide polymorphisms in SRD5A2, ESR1, ESR2  
and ATF3 with hypospadias. 
 
  
 
Offspring genotype 
 
  
Maternal genotype 
 
Single nucleotide 
polymorphism 
 
Geno-   
 type 
 
      
   Cases 
    n      (%) 
 
RR 95% CI  
P-
value  
 
 
 
PLRTa 
 
      
   Mothers 
    n      (%)  
 
RR 
 
95% CI 
 
 P- 
value 
 
 
 
PLRTb 
 
rs523349 in SRD5A2 
 
  CC 
  CG 
  GG 
 
333   (48%) 
298   (43%) 
  70   (10%) 
ref 
1.1 
1.0 
 
0.9, 1.3 
0.7, 1.5 
 
 
0.60 
0.83 
 
0.87  
 
326   (47%) 
313   (45%) 
  57     (8%) 
ref 
1.0 
0.9 
 
 
0.8, 1.3 
0.6, 1.3 
 
 
0.69 
0.46 
 
0.64 
 
 
 
rs6932902 in ESR1 
 
  GG 
  AG 
  AA 
513   (72%) 
177   (25%) 
  18     (3%) 
ref 
1.5 
2.0 
 
1.2, 2.0 
1.1, 3.8 
 
1×10-3 
0.03 
 
3×10-3  523   (75%)  
159   (23%) 
  16     (2%) 
ref 
1.1 
1.7 
 
0.8, 1.4 
0.7, 3.7 
 
0.61 
0.21 
 
0.42 
 
 
 
rs2987983 in ESR2 
 
  AA 
  AG 
  GG 
345   (49%) 
293   (42%) 
  67   (10%) 
ref 
0.8 
0.8 
 
0.7, 1.0 
0.5, 1.1 
 
0.06 
0.12 
 
0.13  328   (47%) 
297   (43%) 
  72   (10%) 
ref 
1.0 
1.0 
 
0.8, 1.3 
0.7, 1.4 
 
0.97 
0.86 
 
0.98 
 
 
 
rs11119982 in ATF3 
 
  CC 
  CT 
  TT 
163   (23%) 
354   (50%) 
188   (27%) 
ref 
1.2 
1.4 
1.0, 1.6 
1.0, 1.9 
 
0.07 
0.02 
 
0.07  180   (26%) 
332   (48%) 
187   (27%) 
ref 
0.9 
1.1 
 
0.7, 1.1 
0.8, 1.6 
 
0.23 
0.37 
 
0.09 
 
 
 
Percentages do not add up to 100% due to rounding; CI, confidence interval; LRT, likelihood ratio test; n, number; RR, relative risk; aP-value of the 
likelihood ratio test comparing a full model including maternal and offspring genotypes to a reduced model including only maternal genotypes; bP-value of 
the likelihood ratio test comparing a full model including maternal and offspring genotypes to a reduced model including only offspring genotypes. 
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Table 3.  Results of the tests for gene-environment interactions for single nucleotide 
polymorphisms in SRD5A2, ESR1, ESR2 and ATF3. 
 
Single nucleotide 
polymorphism 
 
 Environmental risk factor 
 
 
PLRTa 
 
 
rs523349 in SRD5A2 
 
Exogenous exposure to estrogens 
Small for gestational age 
Hypertension or preeclampsia 
BMI > 25 kg/m2 
First pregnancy 
Multiple pregnancy 
 
7×10-3* 
0.92 
0.04* 
0.17 
0.42 
0.44 
 
rs6932902 in ESR1 
 
Exogenous exposure to estrogens 
Small for gestational age 
Hypertension or preeclampsia 
BMI > 25 kg/m2 
First pregnancy 
Multiple pregnancy 
 
0.45 
0.11 
0.06 
0.89 
0.10 
0.72 
 
rs2987983 in ESR2 
 
Exogenous exposure to estrogens 
Small for gestational age 
Hypertension or preeclampsia 
BMI > 25 kg/m2 
First pregnancy 
Multiple pregnancy 
 
0.42 
0.92 
0.86 
0.28 
0.27 
0.11 
 
rs11119982 in ATF3 
 
Exogenous exposure to estrogens 
Small for gestational age 
Hypertension or preeclampsia 
BMI > 25 kg/m2 
First pregnancy 
Multiple pregnancy  
Fetal exposure to cytokines 
Fetal exposure to cigarette smoke 
 
0.78 
0.11 
0.21 
0.82 
0.40 
0.17 
0.02* 
0.60 
 
LRT, likelihood ratio test; aP-value of the likelihood ratio test comparing a full model including gene-
environment interactions to a reduced model including only offspring genotypes; *indication of gene-
environment interaction. 
22 
 
Table 4.  Results of the parent-of-origin analyses. 
 
  
 
Transmission asymmetry test (TAT) 
    
PO-LRT 
 
  
 
Mothers 
  
Fathers 
 
     
Single nucleotide 
polymorphism 
 
Minor 
allelea 
 
T 
 
NT 
 
RR 
 
95% CI 
 
P-
value  
  
T 
 
NT 
 
RR 
 
95% CI 
 
P- 
value 
 
PTAT 
 
 
RR 
 
P- 
value 
 
 
rs523349 in SRD5A2 
 
G 
 
81 
 
80 
 
1.0 
 
0.7, 1.4  
 
0.94  
 
66 
 
81 
 
0.8 
 
0.6, 1.1 
 
0.22 
 
0.34 
  
1.18 
 
0.27 
 
rs6932902 in ESR1 
 
A 
 
79 
 
43 
 
1.8 
 
1.3, 2.7 
 
1×10-3  
 
58 
 
53 
 
1.1 
 
0.8, 1.6 
 
0.64 
 
0.05 
  
1.61 
 
0.07 
 
rs2987983 in ESR2 
 
G 
 
59 
 
95 
 
0.6 
 
0.5, 0.9 
 
4×10-3  
 
64 
 
82 
 
0.8 
 
0.6, 1.1 
 
0.14 
 
0.33 
  
0.76 
 
0.27 
 
rs11119982 in ATF3 
 
T 
 
83 
 
71 
 
1.2 
 
0.9, 1.6 
 
0.33  
 
111 
 
70 
 
1.6 
 
1.2, 2.1 
 
3×10-3 
 
0.17 
  
0.79 
 
0.25 
 
CI, confidence interval; NT, minor allele not transmitted; PO-LRT, parent-of-origin likelihood ratio test; RR, relative risk; T, minor allele transmitted; TAT, 
transmission asymmetry test; athe least frequent allele in the parents. 
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Figures 
 
Figure 1. Relative risks of hypospadias with 95% confidence intervals for genotypes of (a) rs523349 in 
SRD5A2 within strata of exogenous estrogen exposure (b) rs523349 in SRD5A2 within strata of 
maternal hypertension or preeclampsia and (c) rs11119982 in ATF3 within strata of fetal exposure to 
cytokines. 
 
A 
 
 
B 
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Figure 2. Relative risks of hypospadias with 95% confidence intervals for genotypes of rs523349 in 
SRD5A2 within strata of exogenous estrogen exposure using a reduced model assuming Hardy 
Weinberg equilibrium. 
 
 
 
